NCT07548502 Effect of Night Guard Use on Masseter Muscle Thickness in Children With Bruxism
| NCT ID | NCT07548502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nigde Omer Halisdemir University |
| Condition | Bruxism |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-03-15 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective study aims to evaluate the clinical findings of bruxism and masseter muscle thickness in children aged 10-12 years using ultrasonography, and to assess the effects of night guard use on these parameters over time.
Eligibility Criteria
Inclusion Criteria: 1. Children aged 10-12 years 2. Diagnosis of bruxism based on parental report and clinical findings 3. Willingness to participate 4. Parental consent and child assent obtained Exclusion Criteria: 1. Missing posterior teeth causing unilateral chewing 2. History of psychological disorders 3. Neurological disorders or craniofacial abnormalities 4. Use of medications affecting muscle activity 5. Presence of skeletal malocclusions 6. Ongoing orthodontic treatment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07548502 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 12 Years, studying Bruxism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07548502 currently recruiting?
Yes, NCT07548502 is actively recruiting participants. Contact the research team at aycandal@outlook.com for enrollment information.
Where is the NCT07548502 trial being conducted?
This trial is being conducted at Niğde, Turkey (Türkiye).
Who is sponsoring the NCT07548502 clinical trial?
NCT07548502 is sponsored by Nigde Omer Halisdemir University. The trial plans to enroll 20 participants.